Institution Directory

Clinical trials at Cedars-Sinai Medical Center

Sites in Los Angeles, CA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 5:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

664

Shown on this page

Current sort

Live official records

Conditions: Colorectal Cancer
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 89 Years
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2030
U.S. locations: 6
States / cities: Los Angeles, California • Tampa, Florida • St Louis, Missouri + 3 more

Conditions: Advanced EGFR Positive Solid Tumor
Interventions: ZZ06; Biological
Lead sponsor: Changchun Intellicrown Pharmaceutical Co. LTD; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Los Angeles, California • Fairway, Kansas • The Bronx, New York

Conditions: Solid Tumor
Interventions: CRB-601 monoclonal antibody, Anti-PD-1 monoclonal antibody; Drug
Lead sponsor: Corbus Pharmaceuticals Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 20
States / cities: Birmingham, Alabama • Tucson, Arizona • La Jolla, California + 15 more

Conditions: X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
Interventions: ER004; Biological
Lead sponsor: EspeRare Foundation; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 2
States / cities: Los Angeles, California • St Louis, Missouri

Conditions: Appendicitis Acute, Appendicitis Perforated, Appendicitis With Perforation, Appendicitis Suppurative, Appendicitis Gangrenous
Interventions: Discharge on oral antibiotics; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Neoplasm Malignant
Interventions: Pembrolizumab, Belzutifan, Lenvatinib; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 730 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 16
States / cities: Tucson, Arizona • Duarte, California • Los Angeles, California + 13 more

Conditions: Angelman Syndrome
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2031
U.S. locations: 8
States / cities: Los Angeles, California • San Diego, California • Aurora, Colorado + 5 more

Conditions: Hypochondroplasia
Interventions: Not listed
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: Up to 15 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2043
U.S. locations: 16
States / cities: Phoenix, Arizona • Los Angeles, California • Oakland, California + 13 more

Conditions: Ductus Arteriosus, Patent
Interventions: Percutaneous Patent Ductus Arteriosus Closure (PPC), Responsive Management Intervention, Echocardiogram, cardiac; Device · Combination Product · Diagnostic Test
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 7 Days to 32 Days
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 24
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 19 more

Conditions: Coarctation of the Aorta, Pulmonary Artery Stenosis
Interventions: Catheterized Stenting; Device
Lead sponsor: Renata Medical; Industry
Eligibility: Not listed
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 7
States / cities: Los Angeles, California • Boston, Massachusetts • Cincinnati, Ohio + 3 more

Conditions: In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease
Interventions: Sirolimus Drug Coated Balloon, Plan balloon Angioplasty (POBA); Device
Lead sponsor: Concept Medical Inc.; Industry
Eligibility: 18 Years to 110 Years
Enrollment: 492 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 27
States / cities: Birmingham, Alabama • Gilbert, Arizona • Los Angeles, California + 21 more

Conditions: Aortic Valve Stenosis, Bicuspid Aortic Valve
Interventions: transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR); Procedure
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 50 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2037
U.S. locations: 1
States / cities: Los Angeles, California

About this Cedars-Sinai Medical Center institution page

What this page lists: ClinicalTrials.gov records that list Cedars-Sinai Medical Center in Los Angeles, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Cedars-Sinai Medical Center

Filter and sort this campus

Live official records

ColoCare Study - Colorectal Cancer Cohort

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

Enhanced Recovery After Surgery (ERAS) for Complicated Appendicitis

Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)

Angelman Syndrome Natural History Study

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants

Growth Trial: Study of the Renata Minima Stent

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial

About this Cedars-Sinai Medical Center institution page